Related references
Note: Only part of the references are listed.Betulin and Its Derivatives Reduce Inflammation and COX-2 Activity in Macrophages
Wojciech Szlasa et al.
INFLAMMATION (2023)
Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action
Luis A. Videla et al.
BIOFACTORS (2022)
Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats
Samar A. Antar et al.
LIFE SCIENCES (2022)
Protective effect of orange essential oil on the formation of non-alcoholic fatty liver disease caused by high-fat diet
Qing-Shan Wang et al.
FOOD & FUNCTION (2022)
Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship
James H. Schofield et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Non-alcoholic fatty liver disease
Elizabeth E. Powell et al.
LANCET (2021)
Protective Role of Dietary Capsanthin in a Mouse Model of Nonalcoholic Fatty Liver Disease
Hee Kyoung Joo et al.
JOURNAL OF MEDICINAL FOOD (2021)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway
Hui-Min Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome
Na Young Lee et al.
GUT MICROBES (2020)
Rumex dentatus L. phenolics ameliorate hyperglycemia by modulating hepatic key enzymes of carbohydrate metabolism, oxidative stress and PPARγ in diabetic rats
Rasha H. Elsayed et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Farnesol attenuates oxidative stress and liver injury and modulates fatty acid synthase and acetyl-CoA carboxylase in high cholesterol-fed rats
Mohammad H. Abukhalil et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Flavonoids-mediated SIRT1 signaling activation in hepatic disorders
Ahmed M. Sayed et al.
LIFE SCIENCES (2020)
Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation
Kira L. Diehl et al.
CELLS (2020)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Molecular mechanisms related to the hepatoprotective effects of antioxidant-rich extra virgin olive oil supplementation in rats subjected to short-term iron administration
Cynthia Barrera et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Emerging roles of SIRT1 in fatty liver diseases
Ren-Bo Ding et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
The Role of Nrf2 in Cardiovascular Function and Disease
Sandro Satta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
Alessandra Ferramosca et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation
Rodrigo Valenzuela et al.
FOOD & FUNCTION (2017)
Clinical implications of understanding the association between oxidative stress and pediatric NAFLD
Jake P. Mann et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Possible involvement of Nrf2 and PPARγ up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity
Ayman M. Mahmoud et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development
Pierluigi Ramadori et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Protective effect of betulin on cognitive decline in streptozotocin (STZ)-induced diabetic rats
Ma Chunhua et al.
NEUROTOXICOLOGY (2016)
Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway
Ting Bai et al.
PHARMACOLOGICAL RESEARCH (2016)
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
Joao Marcus Oliveira Andrade et al.
NUTRITION (2014)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
Liver Steatosis and Increased ChREBP Expression in Mice Carrying a Liver Specific SIRT1 Null Mutation under a Normal Feeding Condition
Rui-Hong Wang et al.
International Journal of Biological Sciences (2012)
Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats
Ayman M. Mahmoud et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2012)
Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
Jing-Jie Tang et al.
CELL METABOLISM (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice
Hirokazu Sugimoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1(+/-) Mice: A Role of Lipid Mobilization and Inflammation
Fen Xu et al.
ENDOCRINOLOGY (2010)
SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
Bhaskar Ponugoti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver
Neil R. Kitteringham et al.
JOURNAL OF PROTEOMICS (2010)
Molecular Mechanisms of Alcoholic Fatty Liver
Vishnudutt Purohit et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
Aparna Purushotham et al.
CELL METABOLISM (2009)
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Luis Bujanda et al.
BMC GASTROENTEROLOGY (2008)
Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-induced Metabolic Disorders by Enhancing Fat Oxidation
Jerome N. Feige et al.
CELL METABOLISM (2008)
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis
Tsuguhito Ota et al.
GASTROENTEROLOGY (2007)
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
K Srinivasan et al.
PHARMACOLOGICAL RESEARCH (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi et al.
DIABETOLOGIA (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
NF-kappa B: a key role in inflammatory diseases
PP Tak et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
